What follows covers what each hormone does, how the pair is read together, which ranges labs use, what can skew a result, and what usually happens after a positive screen.
Potassium is usually the clue that prompts a clinician to order renin and aldosterone in the first place. Aldosterone instructs the kidney to hold on to sodium and to send potassium out in the urine, so sustained aldosterone excess tends to pull the potassium level down. A low potassium reading next to high blood pressure is the classic pattern that sends a clinician looking at these two hormones. A normal potassium level does not rule out aldosterone excess, and many people with primary aldosteronism have potassium sitting inside the standard range 1.
Potassium also matters for the test itself, because a low potassium level can blunt aldosterone release and make the screen read lower than it otherwise would.
The Potassium guide covers what the marker is, how it is measured and how to read a result.
Renin starts the hormone cascade that defends blood pressure, and aldosterone is the hormone at the far end of that cascade that tells the kidney to hold on to salt and water.
Renin is an enzyme released by specialised cells in the kidney. They release it when blood flow through the kidney drops, when less sodium arrives at a particular segment of the nephron, or when the nervous system signals that pressure needs support. Renin does not raise blood pressure directly. It cleaves a protein made by the liver, angiotensinogen, into angiotensin I, which is then converted into angiotensin II.
Angiotensin II does two things that matter here. It narrows blood vessels, which lifts pressure quickly, and it stimulates the outer layer of the adrenal gland to release aldosterone.
Aldosterone then acts on receptors in the final stretch of the kidney tubule. It increases sodium reabsorption, and because water follows sodium, circulating volume rises. In exchange, the tubule pushes potassium and hydrogen ions into the urine. Over hours, blood volume and pressure climb, potassium drifts down, and the kidney senses that pressure has been restored, so renin release switches off.
That last step is the part the test exploits. In a working system the loop is self limiting. Rising aldosterone suppresses renin, and falling aldosterone releases it. The two hormones are chained to each other, which is why their relationship carries more information than either number alone.
Because the pair exposes a broken feedback loop that neither number reveals on its own. When the adrenal gland produces aldosterone autonomously, meaning without being asked to by angiotensin II, aldosterone stays up while the kidney, sensing a full tank, shuts renin down. That combination is the fingerprint.
Read alone, each value is ambiguous. An aldosterone near the top of its reference range looks unremarkable in a person who skipped salt that morning or stood up shortly before the draw. A low renin on its own is common and becomes more common with age. Put them side by side, and an aldosterone that refuses to fall while renin is suppressed stands out.
Guideline bodies identify the aldosterone-to-renin ratio as the case detection test for primary aldosteronism 2, and more recent guidance keeps it in that role 3. Research suggests that primary aldosteronism is more common among people with high blood pressure than it was long assumed to be, and that a large share of cases is never identified 4.
One practical caveat sits inside the arithmetic. A ratio is a fraction, so a very low renin can produce a high ratio even when aldosterone is modest. For that reason most laboratories and clinicians require the aldosterone value itself to clear a minimum before a raised ratio is taken seriously.
There is no single universal set of numbers, because laboratories use different assays, different units and different collection conditions. The figures below are typical lab reference ranges, offered for orientation rather than as thresholds to judge yourself against.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Plasma renin activity, upright, usual sodium intake | roughly 0.5 to 4 ng/mL/hour | Not published |
| Direct renin concentration | roughly 5 to 40 µIU/mL | Not published |
| Aldosterone, morning, upright | roughly 3 to 35 ng/dL | Not published |
| Aldosterone-to-renin ratio | screening thresholds commonly fall between 20 and 30 when aldosterone is in ng/dL and renin activity is in ng/mL/hour | Not published |
| Potassium | 3.5 to 5 mEq/L | 4 to 4.5 mEq/L |
These are typical lab reference ranges, and they vary by laboratory, assay, age and sex, as well as by whether the sample was drawn lying down or sitting upright. Always read your result against the range printed on your own report. The potassium figure in the final column is FitScript's optimal range, an optimization target rather than a diagnostic cut-off.
Two details cause most of the confusion. First, renin is reported in two completely different ways. Plasma renin activity measures how much angiotensin I the sample generates over time, often by mass spectrometry methods such as plasma renin activity LC MS MS, and is reported in ng/mL/hour. Direct renin concentration measures the renin protein itself and is reported in µIU/mL or mIU/L. Second, because the denominator changes, the ratio cut-off changes with it. A ratio of 25 means something quite different depending on which renin assay produced it, which is why ratios from two different laboratories should never be compared directly.
A high ratio, especially with an aldosterone level that is clearly not low and a renin that is suppressed, raises the possibility that the adrenal glands are producing aldosterone autonomously. That is the pattern primary aldosteronism produces, and it is the reason the screen exists. It is a signal to test further, not a conclusion.
The underlying biology varies. Aldosterone can come from a single hormone producing nodule in one adrenal gland, or from both glands at once, and small clusters of aldosterone producing cells carrying somatic mutations in genes that govern ion handling have been described in adrenal tissue 5. The condition behaves less like a single switch and more like a spectrum, running from mild autonomy through to florid hormone excess 4.
Why this matters beyond blood pressure numbers. Studies suggest that aldosterone excess contributes to injury in the heart, kidneys and blood vessels through pathways that operate in addition to the pressure itself 5. Primary aldosteronism is associated with higher rates of cardiovascular events than blood pressure matched high blood pressure without aldosterone excess 1, and current clinical guidance frames timely case detection as a priority for that reason 6.
A raised ratio is worth discussing with a clinician promptly rather than filing away, because the next steps are well defined and they are not something to work out alone.
When both hormones sit low, the picture points away from aldosterone excess and toward a system that is simply not being asked for more salt retention. The kidney is sensing adequate or generous volume, so renin stays quiet, and without angiotensin II prompting it, the adrenal gland keeps aldosterone output modest.
Several ordinary things produce that pattern. A high habitual sodium intake expands volume and suppresses renin. Renin output tends to run lower with increasing age. Reduced kidney function changes the signal the kidney sends. Some people simply sit at the low end of both ranges without anything being wrong.
Low renin with high blood pressure, but without elevated aldosterone, is a recognised pattern that a clinician may explore further, since salt and water retention can be driven through the same kidney receptors by signals other than aldosterone. That exploration belongs in a consultation, not in self interpretation, because it depends on potassium, kidney function, blood pressure history and what else is going on.
The useful framing is observation, then possible meaning, then conversation. The observation is a suppressed renin. The possible meaning spans everything from a salty week to a volume expanded state. The next step is a clinician who can look at the whole set.
A high renin means the kidney is sensing that pressure, volume or sodium delivery is lower than it wants, and is pushing the cascade to correct it. The partner value then splits the picture in two.
High renin with high aldosterone describes a system that is working as designed, responding to a stimulus somewhere upstream. Volume depletion does it. So does narrowing of an artery supplying a kidney, which makes that kidney read the whole body as under-perfused. Circulatory states in which the effective blood volume is low while total body fluid is high do it as well. Several commonly prescribed medicines raise renin by design, which is one reason results are always read alongside the full list of what someone takes.
High renin with a low or inappropriately normal aldosterone is a different signal. Here the kidney is calling and the adrenal response is muted, a pattern that can accompany impaired adrenal hormone production and often travels with a potassium level toward the upper end or above the reference range. That combination is worth discussing with a clinician promptly.
Neither pattern is a diagnosis. Renin is a sensitive, twitchy marker that responds to posture, salt, hydration and time of day, so a single high reading is a prompt to look further rather than an answer in itself.
Screening is aimed at people whose blood pressure picture carries features that make hormone driven hypertension more likely. Clinical practice guidance has long defined case detection groups along the following lines 2.
More recent guidance has pushed toward wider case detection among people with high blood pressure rather than restricting testing to the narrowest high risk groups 3, and current clinical reviews make the same argument from the standpoint of missed cases 6.
Whether you fit a screening group is a judgement your clinician makes with your history in front of them. Blood pressure that has never responded the way anyone expected is, in practice, the single most common reason this test gets ordered.
It is an ordinary venous blood draw, but the conditions around it matter more than for most tests, because both hormones respond to posture, time of day and salt intake within minutes to hours.
The usual approach is a morning sample, taken after the person has been up and moving for a while, then seated for several minutes before the needle goes in. Collecting both tubes at the same moment is essential, since the ratio only means something if the numerator and denominator describe the same instant. Laboratories often want to know the posture at collection and will print it on the report.
The laboratory then measures aldosterone and renin. Aldosterone is commonly quantified by mass spectrometry, and renin by either an activity assay or a direct concentration assay. Samples sometimes need particular handling and temperature conditions, which is why collection usually happens at a draw site familiar with the test rather than opportunistically.
Fasting is not typically a requirement, though laboratories differ and the instructions on your requisition govern. Severe sodium restriction in the days beforehand can push renin up and distort the ratio, and a low potassium level can suppress aldosterone, so clinicians often want potassium checked and addressed before they read the screen.
One rule has no exceptions. Do not alter anything you have been prescribed in preparation for a blood test. The ordering clinician decides what, if anything, changes before the draw.
Because the test measures a feedback loop, and several medicines used for blood pressure act directly on that loop. Some raise renin, some suppress it, and some change aldosterone independently, so they can shift the ratio in either direction.
The consequences cut both ways. A medicine that drives renin up can push the ratio down and mask a case that is really there. A medicine that suppresses renin can lift the ratio and produce a positive screen in someone without autonomous aldosterone production. Diagnostic guidance therefore devotes considerable attention to interference and to how results should be read in people who remain on their usual prescriptions 7, and practice guidelines set out the same considerations 2.
In real clinics, people are frequently screened while still taking their medicines, because stopping them is not always safe or practical. A clinician can often interpret the result anyway, particularly when the pattern is unambiguous, and may repeat it under different conditions when it is not. Some medicines interfere so strongly that a result obtained while taking them cannot be interpreted at all, and only the prescribing clinician can judge that and decide what to do about it.
Nothing in this section is an instruction to change a prescription. Treatment decisions belong to a licensed provider who knows your history.
Plenty, which is why standardised collection carries so much weight. The main influences are physiological rather than pathological.
Posture is first. Standing or walking shifts blood toward the lower body, the kidney reads a fall in effective volume, and renin rises within minutes. Aldosterone follows. A sample taken after lying down for an hour and one taken after an hour on your feet can differ substantially in the same person on the same morning.
Time of day matters, since both hormones follow a daily rhythm that peaks in the earlier part of the morning. Sodium intake matters, because a very low salt intake raises renin while a very high intake suppresses it. Potassium status matters, since low potassium restrains aldosterone release. Pregnancy and the phase of the menstrual cycle both alter the system. Reduced kidney function changes renin handling. Acute illness, dehydration and heavy sweating all pull the loop in one direction or another.
Supplements and herbal products belong on the list too, because some influence the same kidney receptors that aldosterone works through. That is one more reason a clinician reviews everything you take, prescribed or not, before reading the result.
The practical takeaway is that one unexpected result taken under uncontrolled conditions deserves a repeat rather than a reaction.
A positive screen leads to confirmatory testing, not to a conclusion. The screen is deliberately tuned to catch cases, which means it accepts a share of positives that will not hold up, and the confirmatory step exists to sort them.
Confirmatory testing works on a simple principle. Normal adrenal glands reduce aldosterone output when the system is deliberately loaded with salt or volume, and autonomous tissue does not. Clinical guidance describes several accepted ways of applying that principle, with the choice depending on the person in front of the clinician, and in certain clear cut situations guidance allows the confirmatory step to be bypassed 3.
When the diagnosis is confirmed, attention turns to whether the excess comes from one adrenal gland or both. That usually involves dedicated adrenal imaging and, frequently, adrenal vein sampling, a procedure in which hormone levels are measured from each side separately. Evidence suggests that separating one sided from two sided disease changes the care path a clinician considers 7, and when tissue is removed, standardised histopathology criteria are used to classify what was found 8. Clinical reviews describe both paths as routine parts of specialist management 6.
What happens next is a conversation with a specialist. Treatment decisions belong to a licensed provider, who evaluates what is appropriate after reviewing the full picture.
Renin and aldosterone are rarely informative on their own. They sit inside an electrolyte and kidney panel, and the surrounding markers do most of the work of interpretation.
Potassium is the closest companion, for the reasons covered earlier. Sodium matters because the hormone pair governs sodium handling, and a sodium level sitting toward the upper end alongside a low potassium is part of the classic pattern. Bicarbonate is worth seeing, since the same tubule exchange that loses potassium can shift acid base balance. Creatinine and estimated filtration rate describe how well the kidney is filtering, which changes how both hormones behave.
Beyond the electrolytes, fasting glucose, HbA1c and a lipid panel describe the metabolic context that so often accompanies high blood pressure, and they inform overall cardiovascular risk.
FitScript's membership covers 150+ biomarkers tested per year, and Atlas, FitScript's AI health advisor, reads each result in the context of the rest of the panel rather than in isolation.
Seeing these markers together is what turns a pair of hormone values into something a clinician can act on.
It cannot diagnose anything. It is a screening ratio, built to decide who is worth investigating further, and it carries both false positives and false negatives by design.
It cannot tell you whether aldosterone excess is coming from one adrenal gland or both, which is the question that most shapes what happens next. It cannot explain high blood pressure that has a different cause, and most high blood pressure does. It cannot be read reliably from a sample collected lying down when the reference range assumes upright, or from a draw taken during an acute illness.
It also cannot be compared across laboratories. Different renin assays and different units move the threshold, so a ratio from one laboratory and a ratio from another are not the same measurement wearing the same name.
Finally, a normal result collected under poor conditions does not carry the weight of a normal result collected under good ones. If the clinical suspicion is strong and the first screen is negative, repeating it under standardised conditions is a reasonable thing for a clinician to suggest.
Any result outside the printed reference range is worth raising, and some combinations are worth raising promptly. High blood pressure together with a potassium level below the reference range sits in that group, as does blood pressure that stays elevated despite several medicines, muscle weakness or cramping alongside a low potassium, or a renin and aldosterone pattern your report flags as abnormal.
Bring the whole picture to the appointment. Useful context includes blood pressure readings taken at home over time, a complete list of everything you take, your recent salt intake, whether the draw was morning or afternoon, and whether you were sitting or lying down. Those details change the interpretation more than most people expect.
Never ignore an abnormal result, and never change a prescription on the basis of a page like this one. This page is educational and not medical advice. Discuss your results and any treatment decisions with a clinician or licensed provider who can see your full history.
For a wider view of the laboratory work-up behind elevated readings, see the guide to blood tests for high blood pressure.
It is a screening calculation that divides the aldosterone level by the renin level from the same blood draw. The pairing matters because the two hormones normally rise and fall together, so an aldosterone that stays high while renin is suppressed is the pattern the ratio is designed to catch. A raised ratio is a reason to test further, not a diagnosis.
Fasting is usually not required for this pair, but laboratories differ, so follow the instructions printed on your requisition. Posture and the time of day generally matter more than food for these two hormones. Ask the ordering clinician what preparation they want before the draw.
Both hormones follow a daily rhythm that peaks earlier in the day, and both respond to posture within minutes. Standing or walking raises renin, so a sample taken after lying down and one taken after an hour on your feet can look quite different. Standardising the timing and posture is what makes the ratio comparable to a reference range.
Often yes, and in practice many people are screened without changing anything. Some medicines push renin up and others push it down, which can shift the ratio in either direction, so the ordering clinician decides whether anything needs to change before the draw and reads the result in light of what you take. Never stop or adjust a prescription on your own.
No. The screen is deliberately set to catch possible cases, which means some positive results will not hold up on further testing. Confirmatory testing is the step that sorts them, and a clinician decides which approach suits your situation.
Yes. A low potassium level alongside high blood pressure is the classic pattern, but a large share of people with autonomous aldosterone production have potassium inside the standard range. A normal potassium is therefore not a reason to skip screening when other features point toward it.
They are two different ways of measuring the same part of the system. Plasma renin activity measures how much angiotensin I a sample generates over time and is reported in ng/mL/hour, while direct renin concentration measures the renin protein itself and is reported in µIU/mL or mIU/L. Because the denominator changes, the ratio cut-off changes with it, so results from two different laboratories should not be compared directly.
Borderline results are common, because posture, salt intake, potassium level, illness and several medicines all move these hormones. A clinician may repeat the draw under more carefully standardised conditions, or check and correct potassium first, before deciding anything. The next step is a conversation about the whole picture rather than a reaction to a single number.